Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Berkowitz

Showing results (381-390 of 497) with videos related to

Pageof 50
Sort By:
European Heart Journal|September 11, 2019
Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trialTamar I de Vries, John W Eikelboom, Jackie Bosch, et al.
International Journal of Cardiology|January 10, 2013
Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challengesFaiez Zannad, Wendy Gattis Stough, Véronique Regnault, et al.
The American Journal of Cardiology|August 29, 2001
Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS)C M O'Connor, W A Gattis, A S Hellkamp, et al.
American Heart Journal|May 15, 2018
Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)Warren H Capell, Marc P Bonaca, Mark R Nehler, et al.
Stroke|January 3, 2020
Atrial Cardiopathy and Nonstenosing Large Artery Plaque in Patients With Embolic Stroke of Undetermined SourceHooman Kamel, Lesly A Pearce, George Ntaios, et al.
Journal of the American Heart Association|June 14, 2022
Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PADConnie N Hess, Iris Baumgartner, Sonia S Anand, et al.
Lancet (London, England)|May 5, 2009
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trialAlexander G G Turpie, Michael R Lassen, Bruce L Davidson, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|October 22, 2019
Regional, sex, and age differences in diagnostic testing among participants in the NAVIGATE-ESUS trialAntonio Arauz, Fabiola Serrano, Lesly A Pearce, et al.
Circulation|July 1, 2016
On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AFChristopher B Fordyce, Anne S Hellkamp, Yuliya Lokhnygina, et al.
American Heart Journal|August 10, 2016
Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF TrialSreekanth Vemulapalli, Anne S Hellkamp, W Schuyler Jones, et al.
Pageof 50

Showing results (381-390 of 497) with videos related to

Sort By:
Pageof 50
European Heart Journal|September 11, 2019
Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trialTamar I de Vries, John W Eikelboom, Jackie Bosch, et al.
International Journal of Cardiology|January 10, 2013
Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challengesFaiez Zannad, Wendy Gattis Stough, Véronique Regnault, et al.
The American Journal of Cardiology|August 29, 2001
Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS)C M O'Connor, W A Gattis, A S Hellkamp, et al.
American Heart Journal|May 15, 2018
Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)Warren H Capell, Marc P Bonaca, Mark R Nehler, et al.
Stroke|January 3, 2020
Atrial Cardiopathy and Nonstenosing Large Artery Plaque in Patients With Embolic Stroke of Undetermined SourceHooman Kamel, Lesly A Pearce, George Ntaios, et al.
Journal of the American Heart Association|June 14, 2022
Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PADConnie N Hess, Iris Baumgartner, Sonia S Anand, et al.
Lancet (London, England)|May 5, 2009
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trialAlexander G G Turpie, Michael R Lassen, Bruce L Davidson, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|October 22, 2019
Regional, sex, and age differences in diagnostic testing among participants in the NAVIGATE-ESUS trialAntonio Arauz, Fabiola Serrano, Lesly A Pearce, et al.
Circulation|July 1, 2016
On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AFChristopher B Fordyce, Anne S Hellkamp, Yuliya Lokhnygina, et al.
American Heart Journal|August 10, 2016
Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF TrialSreekanth Vemulapalli, Anne S Hellkamp, W Schuyler Jones, et al.
Pageof 50